Temporal Bacterial Community Dynamics Vary Among Ulcerative Colitis Patients After Fecal Microbiota Transplantation

被引:262
作者
Angelberger, Sieglinde [1 ]
Reinisch, Walter [1 ]
Makristathis, Athanasios [2 ]
Lichtenberger, Cornelia [1 ]
Dejaco, Clemens [1 ]
Papay, Pavol [1 ]
Novacek, Gottfried [1 ]
Trauner, Michael [1 ]
Loy, Alexander [3 ]
Erry, David B. [3 ]
机构
[1] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, A-1090 Vienna, Austria
[2] Med Univ Vienna, Inst Hyg & Med Microbiol, Dept Clin Microbiol, A-1090 Vienna, Austria
[3] Med Univ Vienna, Fac Life Sci, Dept Microbial Ecol, A-1090 Vienna, Austria
关键词
INFLAMMATORY-BOWEL-DISEASE; RECURRENT CLOSTRIDIUM-DIFFICILE; INTESTINAL MICROBIOTA; CROHNS-DISEASE; GUT MICROBIOTA; THERAPY; RNA; BACTERIOTHERAPY; MANAGEMENT; PROFILES;
D O I
10.1038/ajg.2013.257
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Fecal microbiota transplantation (FMT) from healthy donors, which is an effective alternative for treatment of Clostridium difficile-associated disease, is being considered for several disorders such as inflammatory bowel disease, irritable bowel syndrome, and metabolic syndrome. Disease remission upon FMT is thought to be facilitated by an efficient colonization of healthy donor microbiota, but knowledge of the composition and temporal stability of patient microbiota after FMT is lacking. METHODS: Five patients with moderately to severely active ulcerative colitis (Mayo score >= 6) and refractory to standard therapy received FMT via nasojejunal tube and enema. In addition to clinical activity and adverse events, the patients' fecal bacterial communities were monitored at multiple time points for up to 12 weeks using 16S rRNA gene-targeted pyrosequencing. RESULTS: FMT elicited fever and a temporary increase of C-reactive protein. Abundant bacteria from donors established in recipients, but the efficiency and stability of donor microbiota colonization varied greatly. A positive clinical response was observed after 12 weeks in one patient whose microbiota had been effectively augmented by FMT. This augmentation was marked by successive colonization of donor-derived phylotypes including the anti-inflammatory and/or short-chain fatty acid-producing Faecalibacterium prausnitzii, Rosebura faecis, and Bacteroides ovatus. Disease severity (as measured by the Mayo score) was associated with an overrepresentation of Enterobacteriaceae and an underrepresentation of Lachnospiraceae. CONCLUSIONS: This study highlights the value of characterizing temporally resolved microbiota dynamics for a better understanding of FMT efficacy and provides potentially useful diagnostic indicators for monitoring FMT success in the treatment of ulcerative colitis.
引用
收藏
页码:1620 / 1630
页数:11
相关论文
共 52 条
[21]   Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease [J].
Guo, B. ;
Harstall, C. ;
Louie, T. ;
van Zanten, S. Veldhuyzen ;
Dieleman, L. A. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (08) :865-875
[22]   Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons [J].
Haas, Brian J. ;
Gevers, Dirk ;
Earl, Ashlee M. ;
Feldgarden, Mike ;
Ward, Doyle V. ;
Giannoukos, Georgia ;
Ciulla, Dawn ;
Tabbaa, Diana ;
Highlander, Sarah K. ;
Sodergren, Erica ;
Methe, Barbara ;
DeSantis, Todd Z. ;
Petrosino, Joseph F. ;
Knight, Rob ;
Birren, Bruce W. .
GENOME RESEARCH, 2011, 21 (03) :494-504
[23]   Standard Colonic Lavage Alters the Natural State of Mucosal-Associated Microbiota in the Human Colon [J].
Harrell, Laura ;
Wang, Yunwei ;
Antonopoulos, Dionysios ;
Young, Vincent ;
Lichtenstein, Lev ;
Huang, Yong ;
Hanauer, Stephen ;
Chang, Eugene .
PLOS ONE, 2012, 7 (02)
[24]   Monocolonization with Bacteroides ovatus Protects Immunodeficient SCID Mice from Mortality in Chronic Intestinal Inflammation Caused by Long-Lasting Dextran Sodium Sulfate Treatment [J].
Hudcovic, T. ;
Kozakova, H. ;
Kolinska, J. ;
Stepankova, R. ;
Hrncir, T. ;
Tlaskalova-Hogenova, H. .
PHYSIOLOGICAL RESEARCH, 2009, 58 (01) :101-110
[25]   Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis [J].
Khan, Khurram J. ;
Ullman, Thomas A. ;
Ford, Alexander C. ;
Abreu, Maria T. ;
Abadir, A. ;
Marshall, John K. ;
Talley, Nicholas J. ;
Moayyedi, Paul .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (04) :661-673
[26]   Therapeutic transplantation of the distal gut microbiota [J].
Khoruts, A. ;
Sadowsky, M. J. .
MUCOSAL IMMUNOLOGY, 2011, 4 (01) :4-7
[27]   Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea [J].
Khoruts, Alexander ;
Dicksved, Johan ;
Jansson, Janet K. ;
Sadowsky, Michael J. .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2010, 44 (05) :354-360
[28]   Review article: faecal transplantation therapy for gastrointestinal disease [J].
Landy, J. ;
Al-Hassi, H. O. ;
McLaughlin, S. D. ;
Walker, A. W. ;
Ciclitira, P. J. ;
Nicholls, R. J. ;
Clark, S. K. ;
Hart, A. L. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (04) :409-415
[29]   Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences [J].
Loftus, EV .
GASTROENTEROLOGY, 2004, 126 (06) :1504-1517
[30]   UniFrac: a new phylogenetic method for comparing microbial communities [J].
Lozupone, C ;
Knight, R .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2005, 71 (12) :8228-8235